Moderna today announced an investment of about $500 million to build a state-of-the-art messenger RNA (mRNA) manufacturing plant on the African continent. With this, the goal is to produce up to 500 million doses of vaccines annually, including covid-19 and other injections. Moderna's CEO said that if...
